SG and Zimberelimab w/SRS in the Management of Metastatic Triple Negative BCBM

Conditions: Breast Cancer; Triple Negative Breast Cancer Interventions: Radiation: Stereotactic Radiation; Drug: Zimberelimab; Drug: Sacituzumab govitecan Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials